Clinical response to thalidomide in the treatment of intracranial tuberculomas: case report.

Abstract

We describe a patient with multiple intracranial tuberculomas resistant to standard care with antituberculosis drugs and corticosteroids who responded well to thalidomide. Adjunctive thalidomide may have a role in the management of refractory intracranial tuberculomas, although it should be used conservatively owing to its potential adverse events.

• Authors: Patricia de la Riva, Miguel Urtasun, Tamara Castillo-Trivino, Xabier Camino, Maialen Arruti, Elisabet Mondragón, Adolfo Lopez de Munain
• Journal: Clinical neuropharmacology (Clin Neuropharmacol) 2013 Mar-Apr Vol. 36 Issue 2 Pg. 70-2 ISSN: 1537-162X [Electronic] United States
• PMID: 23503553 (Publication Type: Case Reports, Journal Article, Review)

Chemical References

• Antitubercular Agents
• Thalidomide

Topics

• Adult
• Antitubercular Agents (therapeutic use)
• Clinical Trials as Topic (methods, trends)
• Female
• Humans
• Thalidomide (therapeutic use)
• Treatment Outcome
• Tuberculoma, Intracranial (diagnosis, drug therapy)